PERFORMANCE OF EXISTING CARDIOVASCULAR RISK ASSESSMENT TOOLS IN SUB-SAHARAN AFRICA: A SYSTEMATIC REVIEW

Código QR

PERFORMANCE OF EXISTING CARDIOVASCULAR RISK ASSESSMENT TOOLS IN SUB-SAHARAN AFRICA: A SYSTEMATIC REVIEW

Guardado en:

Detalles Bibliográficos
Autores principales:	Yousif M. Hydoub, Ali Mohamed, Seema Nour
Formato:	article
Lenguaje:	EN
Publicado:	Elsevier 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701 Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/e948e6e745f0434da4e04aae4adc267b
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Barriers and challenges for primary and secondary prevention of heart disease in sub-Saharan Africa
por: Simon Stewart, et al.
Publicado: (2017)

Children’s heart disease in sub-Saharan Africa: Challenging the burden of disease
por: John Hewitson, et al.
Publicado: (2017)

Cardiovascular clinical trials in Africa: opportunities and challenges
por: Marli Terblanche, et al.
Publicado: (2017)

Cardiovascular disease and nutrition: The use of food-based dietary guidelines for prevention in Africa
por: P.T. Pisa, et al.
Publicado: (2017)

Cardiovascular Imaging and Theranostics in Cardiovascular Pharmacotherapy
por: Mattia Cattaneo, et al.
Publicado: (2019)

Hypertension in Africa: Redressing the burden of cardiovascular disease using cost-effective nonpharmacological approaches
por: Gavin R. Norton, et al.
Publicado: (2017)

A hidden menace: Cardiovascular disease in South Africa and the costs of an inadequate policy response
por: Mandy Maredza, et al.
Publicado: (2017)

Cardiovascular Pharmacotherapy Focus
por: Pablo Avanzas
Publicado: (2019)

Inflammation and Cardiovascular Disease: The Future
por: Natalie Arnold, et al.
Publicado: (2021)

The Effect of Testosterone on Cardiovascular Disease and Cardiovascular Risk Factors in Men: A Review of Clinical and Preclinical Data
por: Hargun Kaur, et al.
Publicado: (2021)

Meditation and Cardiovascular Health: What is the Link?
por: Sebastian Schnaubelt, et al.
Publicado: (2019)

COVID-19 Pandemic and Cardiovascular Disease
por: Aniket S Rali, et al.
Publicado: (2020)

Deciphering the Riddles in Nutrition and Cardiovascular Disease
por: Amelia Carro, et al.
Publicado: (2019)

The Association Between Psoriasis and Cardiovascular Diseases
por: Ahmed Zwain, et al.
Publicado: (2021)

Effects of aerospace environments on the cardiovascular system
por: Erdinç Ercan
Publicado: (2021)

Novel Cardiovascular Biomarkers Associated with Increased Cardiovascular Risk in Women With Prior Preeclampsia/HELLP Syndrome: A Narrative Review
por: Esmee ME Bovee, et al.
Publicado: (2021)

New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
por: Alberto J Lorenzatti, et al.
Publicado: (2020)

Viscoelastic Haemostatic Assays in Cardiovascular Critical Care
por: Aniket S Rali, et al.
Publicado: (2021)

Electronic Cigarettes and Cardiovascular Risk: Caution Waiting for Evidence
por: Domenico D’Amario, et al.
Publicado: (2019)

Secondary Prevention of Cardiovascular Disease in Women: Closing the Gap
por: Aarti Thakkar, et al.
Publicado: (2021)

Cardiovascular Outcomes in Trials of New Antidiabetic Drug Classes
por: Chris Wai Hang Lo, et al.
Publicado: (2021)

Coronavirus Disease 2019: Psychological Stress and Cardiovascular Diseases
por: Maki Komiyama, et al.
Publicado: (2021)

The Fourth Trimester: Pregnancy as a Predictor of Cardiovascular Disease
por: Pensée Wu, et al.
Publicado: (2021)

New opportunities for reducing cardiovascular risk in the Russian Federation
por: O. D. Ostroumova, et al.
Publicado: (2020)

Obesity and Cardiovascular Risk After Quitting Smoking: The Latest Evidence
por: Koji Hasegawa, et al.
Publicado: (2019)

Electronic Cigarettes and Cardiovascular Risk: Science, Policy and the Cost of Certainty
por: Olusola A Orimoloye, et al.
Publicado: (2019)

Non-invasive Low-level Tragus Stimulation in Cardiovascular Diseases
por: Yunqiu Jiang, et al.
Publicado: (2020)

Anti-inflammatory Treatment and Cardiovascular Outcomes: Results of Clinical Trials
por: Alberto J Lorenzatti
Publicado: (2021)

Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
por: Rhian M. Touyz, MBBCh, PhD, et al.
Publicado: (2021)

COVID-19: a patient with cardiovascular disease at high risk
por: Irina E. Chazova, et al.
Publicado: (2020)

Trending cardiac biomarkers during pregnancy in women with cardiovascular disease
por: Soohyun Chang, et al.
Publicado: (2021)

24th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy
por: Hector Ventura
Publicado: (2020)

Behavioural Interventions to Reduce Cardiovascular Risk: Where Do We Stand?
por: Gianluigi Savarese
Publicado: (2019)

Atherosclerotic Cardiovascular Disease in Rheumatoid Arthritis: Impact of Inflammation and Antirheumatic Treatment
por: Anne Mirjam Kerola, et al.
Publicado: (2021)

Assessing Atherosclerotic Cardiovascular Disease Risk with Advanced Lipid Testing: State of the Science
por: Charles Amir German, et al.
Publicado: (2020)

Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
por: Ernest Spitzer, et al.
Publicado: (2020)

Cardiovascular Benefits of New Antidiabetic Drug Classes: A Network Meta-analysis
por: BMY Cheung, et al.
Publicado: (2020)

Excess mortality in Greece during 2020: the role of COVID-19 and cardiovascular disease
por: Demosthenes Panagiotakos, et al.
Publicado: (2021)

Interleukin 6 trans-signalling and the risk of future cardiovascular events in men and women
por: Per Eriksson, et al.
Publicado: (2021)

Cardiovascular health and risk of hospitalization with COVID-19: A Mendelian Randomization study
por: Marina Cecelja, et al.
Publicado: (2021)